PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC Holdings
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC is an investment fund managing more than 273.66M US dollars. The largest holdings include Karuna Therapeutics, Rallybio and Vaxcyte. In Q3 2022 the fund bought assets of total value of 812K US dollars and sold assets of total value of 61.28M US dollars.
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC portfolio value:
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC quarter portfolio value change:
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC 1 year portfolio value change:
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC portfolio changes
| Period | Buy | Sel |
|---|---|---|
| Q1 2021 | 62248000 | 35876000 |
| Q4 2021 | 15260000 | 15364000 |
| Q2 2022 | 9584000 | 18252000 |
| Q3 2022 | 812000 | 61277000 |
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC 13F holdings
| Stock |
|---|
| Portfolio share: 62.95% Portfolio value: 172.27M Avg. open price: $126.79 Current price: $226.95 P/L: +79.00% Sold -13.11% shares Q3 2022 |
| Portfolio share: 12.01% Portfolio value: 32.86M Avg. open price: N/A Current price: $5.35 P/L: N/A N/A Q3 2021 |
| Portfolio share: 6.81% Portfolio value: 18.62M Avg. open price: N/A Current price: $44.33 P/L: N/A Sold -6.74% shares Q3 2022 |
| Portfolio share: 4.43% Portfolio value: 12.12M Avg. open price: N/A Current price: $13.29 P/L: N/A N/A Q4 2020 |
| Portfolio share: 3.97% Portfolio value: 10.87M Avg. open price: N/A Current price: $17.35 P/L: N/A Sold -15.29% shares Q1 2021 |
| Portfolio share: 2.61% Portfolio value: 7.13M Avg. open price: $4.09 Current price: $1.36 P/L: -66.75% Bought +67.25% shares Q2 2022 |
| Portfolio share: 2.32% Portfolio value: 6.34M Avg. open price: N/A Current price: $5.51 P/L: N/A N/A Q4 2021 |
| Portfolio share: 1.86% Portfolio value: 5.10M Avg. open price: N/A Current price: $12 P/L: N/A N/A Q1 2022 |
| Portfolio share: 1.72% Portfolio value: 4.69M Avg. open price: $5.29 Current price: $2.36 P/L: -55.35% Bought 0.00% shares Q3 2022 |
| Portfolio share: 1.02% Portfolio value: 2.79M Avg. open price: N/A Current price: $1.4 P/L: N/A N/A Q1 2021 |
| Portfolio share: 0.30% Portfolio value: 818K Avg. open price: N/A Current price: $0.97 P/L: N/A Sold -15.21% shares Q2 2022 |
Showing TOP 11 PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR's 13F holdings.
Frequently Asked Questions (FAQ)
What is the biggest position of PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC?
The biggest position of the PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC is Karuna Therapeutics, Inc. (KRTX) with 62.95% portfolio share worth of 172.27M US dollars.
Top 5 PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR's holdings represent 90.17% of the portfolio:
- Karuna Therapeutics, Inc. (KRTX) – 62.95%
- Rallybio Corporation (RLYB) – 12.01%
- Vaxcyte, Inc. (PCVX) – 6.81%
- Akouos, Inc. (AKUS) – 4.43%
- Arcutis Biotherapeutics, Inc. (ARQT) – 3.97%
Who is the portfolio manager of PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC?
The portfolio manager of the PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC is .
What is the total asset value of the PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC portfolio?
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC total asset value (portfolio value) is 273.66M US dollars.
Who is ?
is the portfolio manager of the PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC.
What is (PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC) fund performance?
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR's quarterly performance is +51.63%, annualy +1.54%.
What is the PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC CIK?
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR's Central Index Key is 0001844645 .